Buscar en
Acta Otorrinolaringológica Española
Toda la web
Inicio Acta Otorrinolaringológica Española Dexometasona vía combinada intratimpática-intravenosa para el control del vér...
Journal Information
Vol. 56. Issue 2.
Pages 74-77 (February 2005)
Share
Share
Download PDF
English PDF
More article options
ePub
Vol. 56. Issue 2.
Pages 74-77 (February 2005)
Dexometasona vía combinada intratimpática-intravenosa para el control del vértigo en la enfermedad de Meniere
Combined intratympanic and intravenous dexomethasone to control vertigo in Meniere disease
Visits
...
F.J. García-Purriños
,a
Corresponding author
fgpurrinhos@seorl.net

Francisco José García-Purriños García Servicio de ORL. Hospital de Hellín. C/ Juan Ramón Jiménez, s/n. 02400 Hellín (Albacete)
, E. Ferri**, A. Rosell*, J. Calvo*
* Servicio de ORL. Hospital de Hellín. Albacete
** Servicio de ORL. Hospital de Dolo. Venecia
Article information
Resumen
Objetivo

Combinados con intravenosos, en pacientes con enfermedad de Meniere (EM)

Material y métodos

Se estudiaron 10 pacientes con vértigo debido a EM definitiva en estadios 4-5 ó 6, según los criterios de la American Academy of Otolaryngology (AAO) de 1995. Se infiltró la dexometasona a través de una incisión timpánica, a la vez que por vía intravenosa se inyectó una dosis única de 16 miligramos de dexometasona. Posteriormente se estudió el número de episodios de vértigo entre los meses 18 y 24 del tratamiento y se compara con el número de episodios 6 meses antes del tratamiento

Resultados

En todos los pacientes se produjo una mejoría clínica. En uno se debió repetir el tratamiento a los 6 meses. En un grupo de pacientes se observó un cierto grado de ganancia auditiva

Conclusiones

El uso de dexometasona vía combinada puede ser útil en el control del vértigo en EM para evitar o ser un paso previo a otros tratamientos más agresivos

Palabras clave:
Corticoides intratimpánicos
Enfermedad de Meniere
Abstract
Objective

To verify the result in the use of intratympanic corticosteroids, combined with intravenous, in patients with Meniere disease (MD)

Material and methods

Ten patients with vertigo due to MD in stages 4-5 or 6 were included in the study. Combined intratympanic and intravenous dexomethasone was infiltrated. The number of episodes among the months 18 and 24 of treatment, comparing them with the number of episodes 6 months before treatment (according to the norms of the American committee for the hearing and the equilibrium, 1995) are studied

Results

All patients improved significantly. In one of them treatment was repeated after 6 months. A number of patients with hearing improvement were observed

Conclusions

The use of combined dexomethasone may be useful to control vertigo due to MD, to avoid or to be a prior step to other more aggressive treatments

Key words:
Intratympanic dexomethasone
Meniere disease

Article

These are the options to access the full texts of the publication Acta Otorrinolaringológica Española
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Acta Otorrinolaringológica Española

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos